| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Jul―19 |
Changes in some immunological parameters after COVID-19: general trends and individual characteristics |
TV Glazanova, ER Shilova, YS Efremova, JB Chubukina, SS Bessmeltsev |
| 2 |
[GO] |
2024―Jan―22 |
The specifics of encephalitis after COVID-19 |
MP Bobrov, VB Voitenkov, EV Ekusheva, ES Kiparisova |
| 3 |
[GO] |
2024―Jan―22 |
Patterns of acute chemical poisonings in a metropolis against the background of the COVID-19 pandemic in 2020-2021 |
SA Solonin, MV Belova, NE Tereshkina, EA Kasholkina, IA Tyurin, MA Godkov, MM Potskhveriya |
| 4 |
[GO] |
2023―Okt―10 |
Heart disease in young elite athletes having a history of COVID-19 |
LM Makarov, VN Komolyatova, II Kiselyova, DA Besportochny, AG Akopyan, AV Dmitrieva, NV Aksenova |
| 5 |
[GO] |
2023―Okt―10 |
Current understanding of epidemiology and pathogenesis of multisystem inflammatory syndrome associated with SARS-CoV-2 in children |
YuE Konstantinova, AA Vilnits, MK Bekhtereva, LA Alekseeva, OS Glotov, ES Egorova |
| 6 |
[GO] |
2023―Jul―21 |
Particularities of curation of athletes with protracted course of COVID-19 |
LA Balykova, AV Zholinsky, MS Tarasova, SA Ivyanskiy, SA Bazanovich, MV Shirmankina, RA Bespalov, PV Efimov, ZhV Grishina, SA Parastaev |
| 7 |
[GO] |
2023―Mrz―06 |
Results of epidemiological surveillance for COVID-19 among students and teaching staff of the University |
SA Sayganov, AV Liubimova, IM Gasanbekov, AV Meltser, ZV Lopatin, BI Aslanov |
| 8 |
[GO] |
2023―Jan―16 |
Neutralizing antibody creation technologies: case of SARS-CoV-2 |
VP Baklaushev, EM Samoilova, SM Kuznetsova, EV Ermolaeva, GM Yusubalieva, VA Kalsin, AV Lipatova, AV Troitsky |
| 9 |
[GO] |
2022―Dez―27 |
Assessment of cytotoxicity and antiviral activity against SARS-CoV-2 of the mixture of lactoferrin, artemisinin, and azithromycin in vitro |
AA Ryabchenkova, VV Kopat, ER Chirak, EL Chirak, IA Leneva, EA Glubokova, NP Kartashova, NN Kolmakov, IV Dukhovlinov |
| 10 |
[GO] |
2022―Okt―02 |
N protein based vaccine against SARS-CoV-2 produces a strong T cell immune response to N Protein of novel strains |
SO Rabdano, VE Mukhin, VV Makarov, GO Rudakov, EA Ruzanova, SA Arakelov, MR Khaitov, SM Yudin, DS Kryuchko, IA Berzin, AE Evtushenko, VP Trukhin, VI Skvortsova |
| 11 |
[GO] |
2022―Jun―17 |
Dynamics of humoral immunity to SARS-CoV-2 in the professionally homogeneous group of people over a two-year period of COVID-19 outbreak |
VG Pomelova, TA Bychenkova, NI Bekman, NS Osin, YuN Ishkov, KK Styazhkin |
| 12 |
[GO] |
2022―Mai―26 |
Neurophysiological assessment of speech function in individuals having a history of mild COVID-19 |
SA Gulyaev, YuA Voronkova, TA Abramova, EA Kovrazhkina |
| 13 |
[GO] |
2022―Mai―26 |
Primary pre-hospital triage of patients with COVID-19 |
MA Cherkashin, NS Berezin, NA Berezina, AA Nikolaev, DI Kuplevatskaya, VI Kuplevatsky, TM Rakova, IS Shcheparev |
| 14 |
[GO] |
2022―Mai―12 |
Liver damage in patients with COVID-19 |
DA Vologzhanin, AS Golota, TA Kamilova, SV Makarenko, SG Scherbak |
| 15 |
[GO] |
2022―Mai―12 |
Evaluation of the impact of COVID-19 pandemic on overall mortality in Ozyorsk urban district |
MV Osipov, VA Sokolova, AS Kushnir |
| 16 |
[GO] |
2022―Feb―10 |
Development of PCR test for detection of the SARS-CoV-2 genetic variants alpha, beta, gamma, delta |
GA Shipulin, YuA Savochkina, AK Shuryaeva, EE Shivlyagina, AO Nosova, EE Davydova, AR Luparev, TV Malova, SM Yudin |
| 17 |
[GO] |
2021―Sep―30 |
Experimental and clinical evaluation of mefloquine effectiveness against the infection caused by SARS-CoV-2 |
KN Filin, VD Gladkikh, VN Bykov |
| 18 |
[GO] |
2021―Sep―17 |
Respiratory muscle strength in patients after COVID-19 |
OI Savushkina, MM Malashenko, AV Cherniak, EV Krjukov, EA Sinitsyn, KA Zykov |
| 19 |
[GO] |
2021―Jun―30 |
Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection |
YuV Lobzin, AN Uskov, NV Skripchenko, AA Vilnits, MK Bekhtereva, IV Babachenko |
| 20 |
[GO] |
2021―Jun―30 |
Method for quantitative assessment of protective immunity against SARS-CoV-2, its duration and antibody dynamics |
AM Karmishin, NYu Nosov, VB Postupailo, BA Zhigarlovskiy, AA Kruglov, AN Petukhov |
| 21 |
[GO] |
2021―Jun―19 |
Evaluation of efficacy of the amino acid-peptide complex administered intragastrically to golden hamsters experimentally infected with SARS-CoV-2 |
DS Laptev, GA Protasova, SG Petunov, AS Radilov, SV Chepur, AS Gogolevskiy, VA Myasnikov, MA Tyunin, AV Smirnova |
| 22 |
[GO] |
2021―Feb―16 |
Epidemiological characteristics of community-acquired pneumonia during the COVID-19 epidemic in the Russian Federation |
BA Zhigarlovskiy, NF Nikityuk, VB Postupailo, AA Goryaev, EV Belov, NYu Nosov, AM Karmishin, AA Kruglov, IV Borisevich |
| 23 |
[GO] |
2020―Dez―20 |
Dynamics and logic of COVID-19 containment measures |
YuV Raskina, AA Novkunskaya, AA Barchuk |
| 24 |
[GO] |
2020―Dez―20 |
Endothelial dysfunction in COVID-19 patients and clinical application of laser therapy |
AV Kochetkov, NYu Ponomareva, NG Kadnikova, VG Mitkovskij, EN Yampolskaya, VV Lazarev |
| 25 |
[GO] |
2020―Dez―14 |
Effectiveness of immobilized probiotics for complex therapy of novel coronavirus infection COVID-19 in hospital settings |
NG Bomshteyn, YuV Bolotov, IA Kim, DV Trukhin |
| 26 |
[GO] |
2020―Dez―13 |
Using experimental ex vivo models to develop COVID-19 pathogenetic therapy and complications prevention agents |
DS Laptev, SG Petunov, OV Nechaykina, DV Bobkov, AS Radilov |
| 27 |
[GO] |
2020―Dez―03 |
Surgical care arrangement at the general hospital during the COVID-19 pandemic |
YaA Nakatis, VA Ratnikov, VA Kashchenko, AV Lodygin, AI Mitsinskaya, MA Mitsinskii, AD Akhmetov |
| 28 |
[GO] |
2020―Dez―02 |
Sars-CoV-2 in the context of coronaviruses and animal models of COVID-19 |
AA Korenkova, VV Bahmetjev, KS Gorbunov |
| 29 |
[GO] |
2020―Nov―30 |
COVID-19 in ophthalmic practice |
KhP Takhchidi, NKh Takhchidi, MKh Movsesian |
| 30 |
[GO] |
2020―Aug―19 |
Development of the kit for diagnostics of COVID-19 by real time RT-PCR |
AK Shuryaeva, TV Malova, EE Davydova, YuA Savochkina, EV Bogoslovskaya, RR Mintaev, GM Tsyganova, EE Shivlyagina, ASh Ibragimova, AO Nosova, GA Shipulin, SM Yudin |
| 31 |
[GO] |
2020―Aug―19 |
Inobvious pathogenetic links of mechanisms effects on the human organism of the SARS-CoV-2 virus |
IB Ushakov, AN Parfyonov, RA Bondarenko, VN Komarevtsev |
| 32 |
[GO] |
2020―Aug―18 |
Hyperbaric oxygen therapy in treatment of COVID-19 complicated cases: first application experience review |
ED Mozgovoy, YuD Udalov, MV Ochkolias |
| 33 |
[GO] |
2020―Aug―18 |
Study of the effectiveness of methylprednisolone at different stages of inpatient care for patients with pneumonia caused by a new COVID-19 coronavirus infection |
EE Arinina, RT Tairova, AB Berdalin, SS Gujev, NA Glotova, YuV Rubleva, MA Bulatova, BB Polyaev, DA Terechov, NA Shamalov |
| 34 |
[GO] |
2020―Aug―17 |
Medical evacuation of patients COVID-19 |
NN Baranova, AV Akin'shin, SF Goncharov, MA Meshkov, KM Zelentsov, VP Pys'mennij |
| 35 |
[GO] |
2020―Aug―17 |
Countermeasures against the introduction and spread of coronavirus infection COVID-19 in medical organizations |
VV Nikiforov, TG Suranova, VN Komarevtsev, SYu Khlutkov, VI Skvortsova |
| 36 |
[GO] |
2020―Aug―10 |
Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2 |
KN Filin, IA Berzin, VN Bykov, VD Gladkikh, SYa Loginova, SV Savenko, VN Schukina |
| 37 |
[GO] |
2020―Aug―08 |
Actual problems of psychological support of healthcare workers in infectious hospitals for patients with COVID-19 in the territory of the Krasnoyarsk region |
MS Sevostyanova, NV Selezneva, PA Chernomurova, ZS Kharchenko, KV Glushkova, AO Fetisov, AV Sapova, EV Semichev |
| 38 |
[GO] |
2020―Jul―30 |
Genetic determinants of the response to coronavirus infection COVID-19 |
SV Poyarkov, VV Makarov, SA Kraevoy, SM Yudin |
| 39 |
[GO] |
2020―Jul―30 |
Effect of physical activity level on the course of pneumonia caused by COVID-19 |
AS Samoylov, YuD Udalov, SE Nazaryan, AV Naikina |
| 40 |
[GO] |
2020―Jul―29 |
Justification of the possible directions of pathogenetic therapy of a new coronavirus infection |
YuV Lobzin, MB Ivanov, EB Shustov, VL Rejnyuk, AV Fomichev, AE Sosyukin, BS Litvincev |
| 41 |
[GO] |
2020―Jul―29 |
Clinical and epidemiological features of the new coronavirus infection COVID 19 in the central black region |
IE Esaulenko, VI Popov, TN Petrova, AYu Goncharov |
